Papers
6
Total Citations
40
H-Index
3
About
Ho Won Kang is a leading urologic oncologist whose research focuses on prostate and renal cancers, with a particular emphasis on optimizing treatment strategies and understanding national practice patterns. His most impactful work includes a landmark 2019 population-based study analyzing national practice patterns and direct medical costs for prostate cancer in Korea over a decade, using comprehensive data from the Korean National Health Insurance Service (15 citations). This study provided critical insights into healthcare resource utilization and economic burden. Dr. Kang has made significant contributions to high-risk prostate cancer management, as evidenced by his 2014 review on radical prostatectomy for high-risk disease (13 citations), and has advanced surgical outcomes research through predictive modeling for organ-confined disease after robot-assisted radical prostatectomy. His work spans from large-scale epidemiological analyses to nuanced investigations of sarcopenia's role in biochemical recurrence using MRI-based metrics. With over 40 total citations across his most-cited works, Dr. Kang's research bridges clinical practice, health policy, and surgical innovation, establishing him as a key figure in Korean urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2Current Status of Radical Prostatectomy for High-Risk Prostate Cancer13 citations · 2014
- 3
- 4
- 5
- 6